Candidates for Systemic Therapy for Psoriasis
1 clinical trials · Condition
◉ Watch Candidates for Systemic Therapy for Psoriasis
| Record | Firm | Date |
|---|---|---|
| A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis (NCT00287118) | Merck KGaA, Darmstadt, Germany | 2004-10-27 |
Track Candidates for Systemic Therapy for Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.